Skip to main content

Table 2 Multidimensional Health Assessment Questionnaire results among participants reporting joint pain

From: Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection

 

HCV/HIV-

HCV-

HIV-

Coinfected

Monoinfected

Monoinfected

Physical Function Score (Mean(SD))

2.4 (2.0)

2.6 (1.5)

3.3 (2.1)

Pain (Mean(SD))

6.5 (2.7)

5.6 (2.7)

6.2 (3.2)

Patient Global (Mean(SD))

3.9 (3.3)

4.4 (2.4)

4.9 (1.7)

RAPID3 (Mean(SD))

12.8 (6.3)

12.6 (4.9)

14.3 (5.6)

Emotional Score*(Mean(SD))

4.2 (2.7)

3.7 (2.4)

3.7 (2.3)

Total Symptoms (Mean(SD))**

18.6 (10.4)

17.6 (9.8)

14.2 (10.8)

Depression, n (%)

28 (64%)

33 (50%)

12 (80%)

Anxiety, n (%)

34 (77%)

34 (51%)

10 (67%)

Sleep Disturbance, n (%)

32 (73%)

41 (62%)

10 (67%)

Dry Eyes, n (%)

6 (14%)

19 (29%)

0 (0%)

Dry Mouth n (%)

20 (45%)

32 (48%)

3 (20%)

Numbness/tingling n (%)

18 (41%)

18 (27%)

1 (7%)

Myalgias, n (%)

19 (43%)

17 (26%)

1 (7%)

Morning Stiffness, n (%)

29 (66%)

44 (67%)

8 (53%)

Fatigue Scale (Mean(SD))

4.53 (3.68)

4.73 (3.44)

3.97 (3.82)

≥20 Symptoms Reported

42 (45%)

43 (54%)

7 (23%)

  1. Only patients reporting joint pain completed the MD-HAQ. *The MD-HAQ includes an emotional function assessment in which depression, anxiety and sleep disturbance each ranked as none (0), mild (1.1), moderate (2.2) or severe (3.3). The total “emotional score” is the combined sum of these three components (range 0–9.9).
  2. **The MD-HAQ contains a 60-item review of systems (including depression, anxiety, sleep disturbance, dry eyes, dry mouth, numbness/tingling, myalgias, and morning stiffness. There is additionally a visual analog scale for fatigue.